Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1
about
The Modulation of Apoptotic Pathways by GammaherpesvirusesRecent advances in understanding Kaposi's sarcoma-associated herpesvirusKSHV: pathways to tumorigenesis and persistent infectionTargeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and FutureHsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteinsHsp70 Isoforms Are Essential for the Formation of Kaposi's Sarcoma-Associated Herpesvirus Replication and Transcription CompartmentsThe tandem affinity purification technology: an overview.A Hsp40 chaperone protein interacts with and modulates the cellular distribution of the primase protein of human cytomegalovirus.Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Unfolded protein response-induced ERdj3 secretion links ER stress to extracellular proteostasis.Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeuticsLatent KSHV infection increases the vascular permeability of human endothelial cells.Members of the Hsp70 Family Recognize Distinct Types of Sequences to Execute ER Quality Control.The KSHV K1 Protein Modulates AMPK Function to Enhance Cell Survival.Analysis of protein expression profiles in the thymus of chickens infected with Marek's disease virus.Transcriptional and Bioinformatic Analysis Provide a Relationship between Host Response Changes to Marek's Disease Viruses Infection and an Integrated Long Terminal Repeat.Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cellsTargeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies.A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.Broad action of Hsp90 as a host chaperone required for viral replication.AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV.Review of latent and lytic phase biomarkers in Kaposi's sarcoma.Biology and oncogenicity of the Kaposi sarcoma herpesvirus K1 protein.Immune control of oncogenic γ-herpesviruses.The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication.Inhibition of hepatitis C virus using siRNA targeted to the virus and Hsp90.Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic ApproachLymphoid hyperplasia and lymphoma in KSHV K1 transgenic mice.
P2860
Q26747452-35DA289A-C110-45F7-8221-D9EF2E32C8A9Q26751238-0B6CF8A0-E798-4396-B62D-D3A8C7B148C6Q27026000-3C8FBCBA-9E44-4947-9D85-4AF5C5389217Q28081199-8EA47440-49DB-4EBD-8A84-3BD6AF558E13Q28485399-BBDA577D-69E1-4C8C-ADC0-7DFFDB3A88C3Q28551082-10839B21-B9F8-4C6B-9185-314E2A15FD77Q34172439-3E09405E-09BC-48E7-9EF4-F6B2942B1B53Q34468973-A47E2428-0D4A-4B13-92B4-9635C791D5F1Q34615002-49F80D6B-1A69-4524-B581-6A884E5A909FQ34923990-5343D9AF-62FC-4B9E-BBCD-CB05DDFC4C22Q35376259-F83B36E2-0797-43D8-855C-6226525C1CBFQ35553639-1CA5867A-CD79-4D30-847D-ED901FFA4F28Q36108704-EF7F50D4-210A-4C65-93D3-D852A531CC6FQ36187455-2A5F5527-579B-4F5E-AA85-62ED5D396FECQ36535832-C6641A03-67E9-4EF1-B510-A687972F159FQ36834388-6D956726-E6CF-4742-BC1C-A1C818C5B927Q37123188-AF8CCBBE-1F6E-4231-B214-4A7F186DECFDQ37235682-08B669AF-C301-44BC-B449-F870452429AFQ37245887-60783582-57F4-4DEA-B348-35FE7DCFF333Q37966479-CFD8F6B1-078D-4488-9D77-E35B83DBBD5FQ38073761-75BDE34B-76E8-4B19-9F31-BFB5BBBB539BQ38144129-850A88CB-E2FB-43BA-831F-66BC4AFD3EB1Q38550685-32CC9E24-3895-42A7-ACBF-76AAFE1C48BBQ38587362-8D75E780-989E-430E-B072-1A85C2A45877Q38764215-6AEBE9BE-2DA0-4E57-BCA2-515AA3289E71Q40446960-D640F157-E6D1-4187-8C67-28F7E05837D5Q41660505-7CF57712-4A22-4E58-BE64-E0EDDA22EB98Q42183981-2BB6DBF0-28A0-4264-BFDF-3E0095F82A48
P2860
Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@ast
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@en
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@nl
type
label
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@ast
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@en
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@nl
prefLabel
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@ast
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@en
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@nl
P2860
P356
P1433
P1476
Hsp90 and Hsp40/Erdj3 are requ ...... -apoptotic function of KSHV K1
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2010.124
P407
P577
2010-04-26T00:00:00Z
P5875
P6179
1007802923